The biomarkers for long COVID that keep surfacing in research point to a persistently activated immune system. Studies report differences in cytokines, chemokines, and interferon signaling between people with long COVID and those who have recovered. No single marker diagnoses the condition, but the biology is measurable, and understanding it explains why so many people feel unwell while their standard labs read normal.
Key takeaways
- Long COVID research consistently implicates the immune system, not a single broken organ or one tidy lab value.
- A recurring theme is the type I interferon response: the antiviral signaling axis staying active or dysregulated well after the acute infection.
- Markers studied across the literature include the interferon-inducible chemokines CXCL10 and CXCL11, alongside IL-6, TNF, and other chemokines.
- These are group-level patterns from research, not a diagnostic test for any individual.
- Profiling inflammation markers over time is a research and monitoring approach, to be read with your own doctor, not a diagnosis of long COVID.
What does the research say about long COVID and the immune system?
The strongest recurring finding is that long COVID looks like an immune problem. In a 2023 study in Nature, Klein and colleagues profiled the immune systems of people with long COVID and found patterns that distinguished them from people who had recovered, including differences in circulating immune signals and hormones. The work did not reduce long COVID to one cause. It described a system that behaves differently, across many markers at once.
A 2025 paper in Nature Immunology built on this by examining soluble biomarkers associated with long COVID in large patient cohorts. Together these studies point in the same direction: the signal lives in the pattern of immune signaling proteins in the blood, which is what proteomic profiling measures.
What are the main biomarkers for long COVID in the literature?
Several families of inflammation-related proteins recur across long COVID research. Each sits on a proteomic inflammation panel:
- The interferon signature. Type I interferons (IFN-alpha, IFN-beta) coordinate the antiviral response. When that response stays switched on, it drives interferon-inducible chemokines such as CXCL10 (IP-10) and CXCL11, which is why those chemokines are studied as readouts of interferon activity.
- IL-6. A keystone cytokine in inflammation, described by Hunter and Jones as sitting at the center of the acute and chronic inflammatory response. It appears throughout post-viral research.
- TNF. A core inflammatory cytokine involved in sustained immune signaling.
- Chemokines. Signaling proteins that recruit immune cells, including CCL2 (MCP-1) and CX3CL1 (fractalkine), studied in the context of ongoing inflammation.
Naming these markers is not the same as claiming any one of them causes long COVID. The honest reading is that a cluster of immune signals behaves abnormally, and the cluster is what carries information.
Why is long COVID inflammation hard to see on routine labs?
Routine bloodwork measures a short list of markers against wide population ranges, and it is designed to rule out other conditions rather than to characterize immune signaling. A single interferon-inducible chemokine is not on a standard panel. Neither is a broad readout of cytokine activity. So a person can have a genuinely dysregulated immune profile and still return a clean CBC, a normal thyroid panel, and ferritin inside range.
This is the source of a very specific kind of exhaustion: being told everything looks fine when your body is telling you it is not. Normal on a narrow panel is a statement about that panel, not a verdict on your whole immune system.
Can inflammation profiling diagnose long COVID?
No, and this is where honesty matters most. There is no validated diagnostic blood test for long COVID, and the research patterns above are drawn from groups, not tuned to score an individual as positive or negative. Profiling inflammation markers is a research and monitoring tool. It can show where your values sit against a healthy reference and, more usefully, how they shift when you retest over time.
If you are wondering whether a measured immune signal could confirm the condition, we cover that directly in whether there is a blood test for long COVID. And because the interferon response comes up so often across post-viral illness, it has its own deeper explainer on the type I interferon signature after a viral infection. You can also see the full set of inflammation markers Muno Mirror measures, framed as measurement and benchmarking to discuss with your doctor, never as a diagnosis.
Frequently asked questions
What are the main biomarkers for long COVID?
Research points to immune signaling proteins rather than a single marker. Recurring examples include the type I interferon response and its induced chemokines CXCL10 and CXCL11, plus IL-6, TNF, and other chemokines. These appear as group-level patterns in studies, not as a diagnostic value for one person.
Is long COVID an inflammatory condition?
Research consistently finds altered immune and inflammatory signaling in people with long COVID compared with those who have recovered. That does not mean a single cytokine causes it or that inflammation is the whole story. The evidence describes a dysregulated immune system, and the specific mechanisms are still being studied.
What is the interferon signature in long COVID?
Type I interferons coordinate the body's antiviral response. In some people this response appears to stay active or dysregulated after infection, which raises interferon-inducible chemokines such as CXCL10 (IP-10) and CXCL11. Those chemokines are studied as measurable readouts of ongoing interferon activity.
Can a blood test measure long COVID inflammation?
A proteomic panel can measure many inflammation markers at once, including interferon-related chemokines and cytokines like IL-6 and TNF, and benchmark them against a healthy reference. This is for research and informational use, to review with your own doctor. It characterizes inflammation signaling; it does not diagnose long COVID.